After skimming on low cap stocks which have huge growth potential but have been on signficant correction, I came across JAGX, a pharmaceutical company focused on developing plant-based, non-opioid, and sustainably derived prescription medicines. Weekly data is showing weakening of sellers. An accumulation / net buying at the current price range has been spotted....
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in...
I remember the call on JAGX 2 years ago, just before it did that 21X rally: Now it dropped significantly, being even lower than the analysts ratings. Can you imagine that Cantor Fitzgerald has a price target of $5.00 for JAGX and the stock is trading at $0.55??
Remember the meme-stock JAGX that did a 21X rally in 3 months? Because i remember exactly to call it just before the bull run: Now it can do it once again! You have the price targets in the chart!
Hi All, my main 3 take-outs from this analysis are the following: 1- Price brke the descending wedge at apical level with huge volumes. The movement was quite predictable as the prices were compressing more and more at the apex 2- My long term targets stays at around 6$-7$, as result of the wedge height projection and the breakout point 3- RSI indicating...
The trent shows squeezing now. Be ready for a jump to 5$
Good potential to go long See chart
The Chart has been on my watchlist for a while IT did some gains earlier but it appears that if there is something brewing in the background IF true and volume kicks in it could hit the target as pointed out on the chart
Jaguar Health, Inc. is a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. July 20, 2020 : Jaguar Health, Inc. announced today that it has submitted to the U.S. Food and Drug Administration's Center for Veterinary Medicine the second-to-last required...